OHSU

Rare Disorders Research Consortium

The OHSU Rare Disorders Research Consortium (RDRC), supported by the OHSU Human Genetics Initiative and the Oregon Clinical & Translational Research Institute, creates a local hub for rare disorders research by promoting interaction and sharing of expertise among the diverse investigators on campus.  Although most genetic disorders are individually rare, their cumulative impact is significant and the technologies and skill sets required for their study are unique.  

The RDRC provides clinical investigators, basic scientists, and families with information about rare disorders studied on campus and the specific expertise of our investigator community, including gene hunting, psychosocial research, epidemiology, stem cell therapy, and more. We hope our website will serve as a resource to professionals and laypersons by providing information about consortium members, rare disorders studied at OHSU, local and national funding opportunities, and linking families with appropriate researchers and rare disorder clinical studies. OHSU has a strong foundation of rare disorders research; the we hope to enhance this through facilitating new collaborations and pooling knowledge and resources.

Medical Genetics charts

Join the RDRC

To learn more or join the Rare Disorders Research Consortium, please contact Allison Gregory, MS (gregorya@ohsu.edu) or Kelly Hamman, MS (hammank@ohsu.edu)

Therapeutics for Rare and Neglected Diseases

A program called Therapeutics for Rare and Neglected Diseases (TRND) received $24 million in the NIH budget for fiscal year 2009.  This is a collaborative drug discovery and development program with oversight provided by the Office of Rare Diseases Research.  TRND will help address the thousands of diseases that receive little attention due to their rarity and limited commercial potential in the biopharmaceutical industry.

nih_logo

 The NIH/Office of Rare Diseases Undiagnosed Diseases Program strives to provide answers to patients with mysterious conditions that have long eluded diagosis and advance medical knowledge about rare and common diseases.